4//SEC Filing
Bhatt Elizabeth 4
Accession 0001209191-21-027993
CIK 0001801777other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 6:29 PM ET
Size
13.5 KB
Accession
0001209191-21-027993
Insider Transaction Report
Form 4
Bhatt Elizabeth
Chief Bus. & Strategy Officer
Transactions
- Sale
Common Stock
2021-04-21$40.38/sh−5,417$218,749→ 2,612 total - Exercise/Conversion
Common Stock
2021-04-21$4.61/sh+9,000$41,490→ 9,000 total - Sale
Common Stock
2021-04-21$39.30/sh−971$38,160→ 8,029 total - Sale
Common Stock
2021-04-21$41.21/sh−2,612$107,649→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-21−9,000→ 301,632 totalExercise: $4.61From: 2020-09-16Exp: 2030-03-06→ Common Stock (9,000 underlying)
Footnotes (4)
- [F1]The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.86 to $39.80, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.95 to $40.94, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.55, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]1/4th of the shares subject to the grant become vested on the Exercisable Date set forth above and 1/48th of the shares subject to the option vest monthly thereafter, provided that the reporting person remains a service provider to the issuer on each such vest date.
Documents
Issuer
Applied Molecular Transport Inc.
CIK 0001801777
Entity typeother
Related Parties
1- filerCIK 0001748622
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 6:29 PM ET
- Size
- 13.5 KB